Clinical observation of spironolactone treatment in patients with chronic heart failure of coronary heart disease
Zheng Wang
Abstract
Zheng Wang
Abstract
Objective To observe the effect of spironolactone treatment in patients with chronic heart failure of coronary heart disease. Methods 80 patients with chronic heart failure of coronary heart disease were randomly divided into therapy group (40 cases) and control group (40 cases).The patients in control group used mainly diuretil, angiotensin converting enzyme inhibitors( ACEI) , β - adrenoceptor blocking drugs and digitalis. On the basis of the above treatment, patients in therapy group used spironolactone instead of triamterene. Clinical effects were evaluated after three- month treatment. Results The total effectiveness of the therapy group was 92.5% , and the total effectiveness of the control group was 75.0% . There was distinctive difference between the two groups (P0.05). Conclusion Spironolactone can improve the clinical therapy effect obviously.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the effect of spironolactone treatment in patients with chronic heart failure of coronary heart disease. Methods 80 patients with chronic heart failure of coronary heart disease were randomly divided into therapy group (40 cases) and control group (40 cases).The patients in control group used mainly diuretil, angiotensin converting enzyme inhibitors( ACEI) , β - adrenoceptor blocking drugs and digitalis. On the basis of the above treatment, patients in therapy group used spironolactone instead of triamterene. Clinical effects were evaluated after three- month treatment. Results The total effectiveness of the therapy group was 92.5% , and the total effectiveness of the control group was 75.0% . There was distinctive difference between the two groups (P0.05). Conclusion Spironolactone can improve the clinical therapy effect obviously.
Key concepts: Medicine, Spironolactone, Heart failure, Digitalis, Internal medicine, Triamterene, Coronary heart disease, Cardiology